Home/Healionics/Max Maginness, PhD

MM

Max Maginness, PhD

President & Chief Operating Officer

Therapeutic Areas

Renal Disease Vascular Access

Healionics Pipeline

Drug	Indication	Phase
STARgraft Vascular Graft	Vascular Access for Hemodialysis in End-Stage Renal Disease (ESRD)	Pre-clinical

Leadership Team at Healionics

Andrew Marshall, PhD

Director & Chief Technology Officer

Director of Research & Development

Ashleigh Cooper, PhD

Director of Quality & Regulatory Affairs

View full Healionics profile